Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Carisma Therapeutics Profit Margin 2012-2025 | CARM

Current and historical gross margin, operating margin and net profit margin for Carisma Therapeutics (CARM) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Carisma Therapeutics net profit margin as of March 31, 2025 is -254.28%.
  
Carisma Therapeutics Annual Profit Margins
Carisma Therapeutics Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.017B $0.020B
Carisma Therapeutics Inc. is a late-stage clinical company which focused on advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The company's advanced product candidate includes Vicineum(TM). Carisma Therapeutics Inc., formerly known as Sesen Bio Inc., is based in CAMBRIDGE, Mass.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.521B 32.46
Zoetis (ZTS) United States $69.359B 25.88
Takeda Pharmaceutical (TAK) Japan $47.920B 9.53
Daiichi Sankyo, - (DSNKY) Japan $43.494B 22.29
BeOne Medicines - (ONC) Cayman Islands $27.892B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.619B 0.00
Merck (MKKGY) Germany $16.901B 12.38
Summit Therapeutics (SMMT) United States $15.834B 0.00
Shionogi (SGIOY) Japan $14.955B 14.98
United Therapeutics (UTHR) United States $12.814B 11.34
Neurocrine Biosciences (NBIX) United States $12.540B 42.95
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $9.739B 0.00
Corcept Therapeutics (CORT) United States $7.882B 64.08
Stevanato Group S.p.A (STVN) Italy $7.598B 46.46
Madrigal Pharmaceuticals (MDGL) United States $6.650B 0.00
Ionis Pharmaceuticals (IONS) United States $6.331B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.037B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.234B 0.00
Hypermarcas (HYPMY) Brazil $2.914B 19.17
Crinetics Pharmaceuticals (CRNX) United States $2.808B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.670B 9.35
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.548B 13.78
NewAmsterdam Pharma (NAMS) Netherlands $2.071B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.021B 0.00
Indivior (INDV) United States $1.888B 8.01
ARS Pharmaceuticals (SPRY) United States $1.776B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.742B 0.00
Endo (NDOI) United States $1.603B 0.00
Ocular Therapeutix (OCUL) United States $1.507B 0.00
Evotec AG (EVO) Germany $1.499B 0.00
Guardian Pharmacy Services (GRDN) United States $1.339B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.166B 23.32
Harrow (HROW) United States $1.150B 0.00
Dyne Therapeutics (DYN) United States $1.142B 0.00
Enliven Therapeutics (ELVN) United States $1.056B 0.00
Verve Therapeutics (VERV) United States $1.003B 0.00
Akebia Therapeutics (AKBA) United States $0.982B 0.00
Collegium Pharmaceutical (COLL) United States $0.961B 5.18
Avadel Pharmaceuticals (AVDL) Ireland $0.899B 0.00
Ardelyx (ARDX) United States $0.882B 0.00
Elite Pharmaceuticals (ELTP) United States $0.780B 0.00
Xeris Biopharma Holdings (XERS) United States $0.741B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xencor (XNCR) United States $0.598B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.579B 0.00
USANA Health Sciences (USNA) United States $0.575B 12.50
KalVista Pharmaceuticals (KALV) United States $0.572B 0.00
Relay Therapeutics (RLAY) United States $0.569B 0.00
AleAnna (ANNA) United States $0.550B 0.00
Bioventus (BVS) United States $0.547B 13.88
Theravance Biopharma (TBPH) United States $0.537B 0.00
Zevra Therapeutics (ZVRA) United States $0.507B 0.00
Siga Technologies (SIGA) United States $0.469B 9.79
Organogenesis (ORGO) United States $0.458B 0.00
Oruka Therapeutics (ORKA) United States $0.435B 0.00
Liminatus Pharma (LIMN) United States $0.432B 0.00
Tourmaline Bio (TRML) United States $0.429B 0.00
Savara (SVRA) United States $0.382B 0.00
Nektar Therapeutics (NKTR) United States $0.368B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.335B 9.06
Heron Therapeutics (HRTX) United States $0.330B 0.00
Aquestive Therapeutics (AQST) United States $0.323B 0.00
Altimmune (ALT) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 24.19
Tonix Pharmaceuticals Holding (TNXP) United States $0.261B 0.00
Aldeyra Therapeutics (ALDX) United States $0.232B 0.00
Nanobiotix S.A (NBTX) France $0.223B 0.00
ProKidney (PROK) United States $0.212B 0.00
MediWound (MDWD) Israel $0.210B 0.00
OmniAb (OABI) United States $0.206B 0.00
Esperion Therapeutics (ESPR) United States $0.202B 0.00
Larimar Therapeutics (LRMR) United States $0.197B 0.00
4D Molecular Therapeutics (FDMT) United States $0.189B 0.00
Profound Medical (PROF) Canada $0.185B 0.00
Aclaris Therapeutics (ACRS) United States $0.169B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Journey Medical (DERM) United States $0.163B 0.00
Galectin Therapeutics (GALT) United States $0.149B 0.00
Lexeo Therapeutics (LXEO) United States $0.139B 0.00
Avita Medical (RCEL) United States $0.135B 0.00
Lyell Immunopharma (LYEL) United States $0.135B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.126B 0.00
Inhibikase Therapeutics (IKT) United States $0.123B 0.00
Achieve Life Sciences (ACHV) Canada $0.122B 0.00
VAXART, INC (VXRT) United States $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.122B 0.00
Korro Bio (KRRO) United States $0.116B 0.00
Protara Therapeutics (TARA) United States $0.115B 0.00
Champions Oncology (CSBR) United States $0.100B 16.41
Corbus Pharmaceuticals Holdings (CRBP) United States $0.098B 0.00
Arch Biopartners (ACHFF) Canada $0.091B 0.00
Cassava Sciences (SAVA) United States $0.088B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Dominari Holdings (DOMH) United States $0.086B 0.00
Fractyl Health (GUTS) United States $0.085B 0.00
Wellgistics Health (WGRX) United States $0.080B 0.00
Vivani Medical (VANI) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.073B 0.00
Surrozen (SRZN) United States $0.072B 0.00
Inotiv (NOTV) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
NRx Pharmaceuticals (NRXP) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Rafael Holdings (RFL) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Context Therapeutics (CNTX) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Telomir Pharmaceuticals (TELO) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.040B 29.78
ElectroCore (ECOR) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
Klotho Neurosciences (KLTO) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Jupiter Neurosciences (JUNS) United States $0.036B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
China SXT Pharmaceuticals (SXTC) China $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
VYNE Therapeutics (VYNE) United States $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
FibroGen (FGEN) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Vivos Therapeutics (VVOS) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Plus Therapeutics (PSTV) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.20
Cosmos Health (COSM) United States $0.013B 0.00
Crescent Biopharma (CBIO) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Ainos (AIMD) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00